CLINICAL TRIAL NETWORK PHARMACY AND CLINICAL SUPPORT (CTN PCS) Release Date: March 7, 2001 NOTICE: NOT-DA-01-023 RFP AVAILABLE: N01DA-1-2200 National Institute on Drug Abuse The National Institute on Drug Abuse (NIDA) is soliciting proposals from qualified businesses to provide resources to support the newly established Clinical Trials Network (CTN). In an effort to dramatically improve drug abuse treatment throughout the country, NIDA established the CTN in September 1999 and has awarded fourteen Regional Research and Training Centers (RRTCs). Each RRTC has contractual agreement with 5-8 Community-based Treatment Programs (CTPs). Multi-site clinical trials will be conducted in these community program sites. This project is to support the work of the CTN in its conducting of clinical trials to evaluate the effectiveness of science- based behavior therapies and/or safe and effective medication therapies. For medication trials, the Contractor shall prepare medication kits for the patients, manage a drug testing quality assurance program, and distributing clinical supplies. No actual clinical or laboratory studies will be conducted under this contract. It is estimated that a three-year incrementally funded, level of effort type contract using work assignments will result from this procurement. The project will include two options, each for an additional year. RFP No. N01DA-1-2200 will be available electronically on or about March 26, 2001, and may be accessed through the NIDA website at the following address: (URL: http://www.nida.nih.gov/RFP/RFPList.html) Please note that the RFP for this acquisition will be streamlined to include only the Work Statement, Deliverables and Reporting Requirements, Special Requirements and Mandatory Qualifications, Technical Evaluation Criteria, and other necessary Proposal Preparation Instructions. All information required for the submission of an offer will be contained in or accessible through the electronic RFP package. Response to the RFP will be due on or about May 10, 2001. Any responsible offeror may submit a proposal which will be considered by the Government. This advertisement does not commit the Government to award a contract. Point of Contact: Kenneth E. Goodling, Contracting Officer National Institute on Drug Abuse, NIH Contracts Management Branch, OPRM 6001 Executive Blvd., Room 3105, MSC 9543 Bethesda, Maryland 20892-9543 Electronic Mail Address: kg25d@nih.gov Telephone: (301) 443-6677 Fax: (301) 443-7595
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |